Page last updated: 2024-11-06

mitomycin and Basal Cell Cancer

mitomycin has been researched along with Basal Cell Cancer in 1 studies

Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tkocz, D1
Crawford, NT1
Buckley, NE1
Berry, FB1
Kennedy, RD1
Gorski, JJ1
Harkin, DP1
Mullan, PB1

Other Studies

1 other study available for mitomycin and Basal Cell Cancer

ArticleYear
BRCA1 and GATA3 corepress FOXC1 to inhibit the pathogenesis of basal-like breast cancers.
    Oncogene, 2012, Aug-09, Volume: 31, Issue:32

    Topics: Antineoplastic Agents; Base Sequence; BRCA1 Protein; Breast Neoplasms; Cell Line, Tumor; Cell Prolif

2012